Avivagen Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a VIVXF research report →
Price Chart
About the company
Avivagen Inc. is a life sciences enterprise that invents and sells specialized products, primarily for animal feed, aimed at bolstering the immune systems of livestock. These solutions are designed to enhance animals' health, leading to improved growth and overall productivity.
- CEO
- G. F. Kym Anthony
- IPO
- 2013
- Employees
- 13
- HQ
- Ottawa, ON, CA
Get TickerSpark's AI analysis on VIVXF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $7.77K
- P/E
- -0.11
- PEG
- -0.00
- P/S
- 0.83
- P/B
- -0.11
- EV/EBITDA
- -2.69
- Div Yield
- 0.00%
- Gross Margin
- 42.62%
- Op Margin
- -99.40%
- Net Margin
- -645.91%
- ROE
- 122.10%
- ROIC
- -916.23%
Latest fiscal year · YoY change
- Revenue
- $939.17K-27.5%
- Gross Profit
- $400.30K-25.1%
- Op Income
- $-4,897,756
- Net Income
- $-6,066,206+5.1%
- EPS
- $-0.09+23.4%
- OCF Growth
- +32.2%
- FCF Growth
- +32.4%
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- 0.35
- RSI (14)
- 52
- Avg Volume
- 98
No earnings-call transcripts are available for VIVXF yet.
- Free Float
- 98.6%
- Shares Outstanding
- 77.69M
- Float Shares
- 76.60M
Our VIVXF coverage
Recent articles, reports, and earnings notes.
No research on VIVXF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate VIVXF report →High Tide (NASDAQ:HITI) and Avivagen (OTCMKTS:VIVXF) Financial Comparison
defenseworld.net · Mar 25
Contrasting Avivagen (OTCMKTS:VIVXF) & Stryker (NYSE:SYK)
defenseworld.net · Feb 20
Avivagen Makes Voluntary Assignment into Bankruptcy Under the BIA
newsfilecorp.com · Apr 24
Avivagen Announces New 500Kg Order for OxC-beta™
businesswire.com · Oct 17
Avivagen Inc. Announces Results for the Third Quarter Ending July 31, 2023
businesswire.com · Sep 29
Avivagen Provides Corporate Updates
businesswire.com · Jul 31
Avivagen Announces New Orders for 1.1 Tonnes of Oxc-Beta™ Livestock Product
businesswire.com · Jul 24
Avivagen Announces TSX Venture Exchange Approval for Extension of Warrants
businesswire.com · Jun 11
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.